NWBO
Northwest Biotherapeutics, Inc.
Price Chart
Latest Quote
$0.19
+0.00 (+0.00%)
Current Price
| Previous Close | $0.19 |
| Open | $0.19 |
| Day High | $0.20 |
| Day Low | $0.19 |
| Volume | 514,258 |
Stock Information
| Shares Outstanding | 1.64B |
| Total Debt | $63.99M |
| Cash Equivalents | $1.79M |
| Revenue | $1.50M |
| Net Income | $-45.27M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $312.24M |
| EPS (TTM) | $-0.03 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $394.16M |
| Sales | $1.50M |
| Income | $-45.27M |
| Book/sh | $-0.03 |
| Cash/sh | $0.00 |
| Employees | 105 |
Financial Ratios
| Quick Ratio | 0.02 |
| Current Ratio | 0.07 |
Returns & Margins
| ROA | -62.18% |
| Operating Margin | -2206.48% |
Ownership
| Insider Ownership | 4.26% |
| Institutional Ownership | 0.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.71 |
| PEG | 1.72 |
| P/S | 208.57 |
| P/B | -6.13 |
Analyst Data
| Recommendation | none |
| Target Price | $1.00 |
Technical Indicators
| SMA20 | $0.20 |
| SMA50 | $0.21 |
| SMA200 | $0.24 |
| RSI | 25.00 |
| ATR | 0.0136 |
| Shares Float | 1.61B |
| Short Float | 15.09% |
| Short Ratio | 13.54 |
| Volatility | -0.66 |
| Rel Volume | 0.54 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| 6 Months | nan% |
| YTD | nan% |
| Year | nan% |
| 3 Years | nan% |
| 5 Years | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.19 | 1,363,900 |
| 2026-06-17 | $0.19 | 2,768,000 |
| 2026-06-16 | $0.19 | 2,033,900 |
| 2026-06-15 | $0.19 | 1,412,400 |
| 2026-06-12 | $0.20 | 2,918,600 |
| 2026-06-11 | $0.19 | 2,870,300 |
| 2026-06-10 | $0.19 | 1,374,300 |
| 2026-06-09 | $0.19 | 2,252,100 |
| 2026-06-08 | $0.20 | 1,626,400 |
| 2026-06-05 | $0.20 | 1,926,700 |
| 2026-06-04 | $0.21 | 1,736,400 |
| 2026-06-03 | $0.20 | 1,373,200 |
| 2026-06-02 | $0.21 | 6,678,700 |
| 2026-06-01 | $0.22 | 2,407,000 |
| 2026-05-29 | $0.23 | 1,945,600 |
| 2026-05-28 | $0.22 | 1,709,600 |
| 2026-05-27 | $0.21 | 1,349,900 |
| 2026-05-26 | $0.21 | 7,556,600 |
| 2026-05-22 | $0.23 | 2,172,300 |
| 2026-05-21 | $0.23 | 2,694,400 |
| 2026-05-20 | $0.25 | 1,204,600 |
| 2026-05-19 | $0.25 | 3,697,100 |
About Northwest Biotherapeutics, Inc.
Northwest Biotherapeutics, Inc., a biotechnology company, engages in the development of personalized immune therapies for cancer. The company develops DCVax, a platform technology which uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. It also engages in the development of its lead product candidate DCVax-L in Phase III trials for glioblastoma multiforme brain cancer. In addition, the company develops DCVax-Direct in Phase I trials to treat inoperable solid tumors. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $1,382,000 | $1,932,000 | $1,683,000 | $1,005,000 |
| Operating Revenue | $1,382,000 | $1,932,000 | $1,683,000 | $1,005,000 |
| Expenses | ||||
| Interest Expense | $7,767,000 | $5,241,000 | $6,068,000 | $5,011,000 |
| Total Expenses | $67,890,000 | $57,440,000 | $68,864,000 | $53,707,000 |
| Other Income Expense | $-9,503,000 | $-1,850,000 | $-31,783,000 | $236,839,000 |
| Other Non Operating Income Expenses | $-819,000 | $-78,000 | $33,000 | $-647,000 |
| Net Non Operating Interest Income Expense | $-7,767,000 | $-5,241,000 | $-6,068,000 | $-5,011,000 |
| Interest Expense Non Operating | $7,767,000 | $5,241,000 | $6,068,000 | $5,011,000 |
| Operating Expense | $67,890,000 | $57,440,000 | $68,864,000 | $53,707,000 |
| General And Administrative Expense | $33,002,000 | $29,710,000 | $33,353,000 | $33,399,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-83,778,000 | $-62,599,000 | $-105,032,000 | $179,126,000 |
| Net Interest Income | $-7,767,000 | $-5,241,000 | $-6,068,000 | $-5,011,000 |
| Normalized Income | $-75,094,000 | $-60,827,000 | $-73,216,000 | $5,761,220 |
| Net Income From Continuing And Discontinued Operation | $-83,778,000 | $-62,599,000 | $-105,032,000 | $179,126,000 |
| Total Operating Income As Reported | $-66,508,000 | $-55,508,000 | $-67,181,000 | $-52,702,000 |
| Net Income Common Stockholders | $-85,192,000 | $-64,373,000 | $-105,032,000 | $179,126,000 |
| Net Income | $-83,778,000 | $-62,599,000 | $-105,032,000 | $179,126,000 |
| Net Income Including Noncontrolling Interests | $-83,778,000 | $-62,599,000 | $-105,032,000 | $179,126,000 |
| Net Income Continuous Operations | $-83,778,000 | $-62,599,000 | $-105,032,000 | $179,126,000 |
| Pretax Income | $-83,778,000 | $-62,599,000 | $-105,032,000 | $179,126,000 |
| Special Income Charges | $-14,393,000 | $-5,403,000 | $-2,691,000 | $-165,000 |
| Operating Income | $-66,508,000 | $-55,508,000 | $-67,181,000 | $-52,702,000 |
| Per Share | ||||
| Diluted EPS | $-0.07 | $-0.06 | $-0.10 | $-0.06 |
| Basic EPS | $-0.07 | $-0.06 | $-0.10 | $0.21 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $64,121,220 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-65,283,000 | $-53,853,000 | $-65,648,000 | $-52,763,000 |
| Total Unusual Items | $-8,684,000 | $-1,772,000 | $-31,816,000 | $237,486,000 |
| Total Unusual Items Excluding Goodwill | $-8,684,000 | $-1,772,000 | $-31,816,000 | $237,486,000 |
| Reconciled Depreciation | $2,044,000 | $1,733,000 | $1,500,000 | $586,000 |
| EBITDA (Bullshit earnings) | $-73,967,000 | $-55,625,000 | $-97,464,000 | $184,723,000 |
| EBIT | $-76,011,000 | $-57,358,000 | $-98,964,000 | $184,137,000 |
| Diluted Average Shares | $1,242,237,000 | $1,119,191,000 | $1,015,852,000 | $1,007,869,000 |
| Basic Average Shares | $1,242,237,000 | $1,119,191,000 | $1,015,852,000 | $873,517,000 |
| Diluted NI Availto Com Stockholders | $-85,192,000 | $-64,373,000 | $-105,032,000 | $179,126,000 |
| Otherunder Preferred Stock Dividend | $1,414,000 | $1,774,000 | $0 | $0 |
| Other Special Charges | $14,393,000 | $5,403,000 | $2,691,000 | $165,000 |
| Gain On Sale Of Security | $5,709,000 | $3,631,000 | $-29,125,000 | $237,651,000 |
| Research And Development | $34,888,000 | $27,730,000 | $35,511,000 | $20,308,000 |
| Selling General And Administration | $33,002,000 | $29,710,000 | $33,353,000 | $33,399,000 |
| Other Gand A | $33,002,000 | $29,710,000 | $33,353,000 | $33,399,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-96,405,000 | $-67,691,000 | $-130,021,000 | $-125,909,000 |
| Total Assets | $26,728,000 | $27,865,000 | $31,323,000 | $40,160,000 |
| Total Non Current Assets | $22,666,000 | $23,740,000 | $21,898,000 | $22,870,000 |
| Other Non Current Assets | $365,000 | $361,000 | $345,000 | $1,036,000 |
| Goodwill And Other Intangible Assets | $1,918,000 | $1,918,000 | $1,918,000 | $1,918,000 |
| Other Intangible Assets | $1,292,000 | $1,292,000 | $1,292,000 | $1,292,000 |
| Current Assets | $4,062,000 | $4,125,000 | $9,425,000 | $17,290,000 |
| Other Current Assets | $1,887,000 | $1,999,000 | $2,460,000 | $2,121,000 |
| Cash Cash Equivalents And Short Term Investments | $2,175,000 | $2,126,000 | $6,965,000 | $15,169,000 |
| Cash And Cash Equivalents | $2,175,000 | $2,126,000 | $6,965,000 | $15,169,000 |
| Prepaid Assets | - | - | - | $2,121,000 |
| Debt | ||||
| Net Debt | $60,501,000 | $38,666,000 | $14,564,000 | $17,226,000 |
| Total Debt | $67,440,000 | $45,560,000 | $26,253,000 | $37,938,000 |
| Long Term Debt And Capital Lease Obligation | $32,734,000 | $24,766,000 | $10,361,000 | $30,382,000 |
| Long Term Debt | $28,296,000 | $20,312,000 | $5,991,000 | $25,156,000 |
| Current Debt And Capital Lease Obligation | $34,706,000 | $20,794,000 | $15,892,000 | $7,556,000 |
| Current Debt | $34,380,000 | $20,480,000 | $15,538,000 | $7,239,000 |
| Other Current Borrowings | $34,380,000 | $20,480,000 | $15,538,000 | $7,239,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $121,215,000 | $93,638,000 | $159,426,000 | $164,151,000 |
| Total Non Current Liabilities Net Minority Interest | $52,941,000 | $48,434,000 | $33,421,000 | $30,382,000 |
| Other Non Current Liabilities | $4,700,000 | $4,950,000 | - | - |
| Current Liabilities | $68,274,000 | $45,204,000 | $126,005,000 | $133,769,000 |
| Other Current Liabilities | $2,426,000 | $951,000 | $83,803,000 | $107,034,000 |
| Payables And Accrued Expenses | $31,142,000 | $23,459,000 | $26,310,000 | $19,179,000 |
| Payables | $28,382,000 | $23,459,000 | $26,310,000 | $19,179,000 |
| Other Payable | $9,721,000 | $9,671,000 | $8,668,000 | $8,232,000 |
| Accounts Payable | $18,661,000 | $13,788,000 | $17,642,000 | $10,947,000 |
| Equity | ||||
| Common Stock Equity | $-94,487,000 | $-65,773,000 | $-128,103,000 | $-123,991,000 |
| Total Equity Gross Minority Interest | $-94,487,000 | $-65,773,000 | $-128,103,000 | $-123,991,000 |
| Stockholders Equity | $-94,487,000 | $-65,773,000 | $-128,103,000 | $-123,991,000 |
| Other Equity Interest | $-79,000 | $-79,000 | $-79,000 | $-79,000 |
| Gains Losses Not Affecting Retained Earnings | $3,043,000 | $1,536,000 | $3,145,000 | $357,000 |
| Other Equity Adjustments | $3,043,000 | $1,536,000 | $3,145,000 | $357,000 |
| Retained Earnings | $-1,443,499,000 | $-1,359,721,000 | $-1,297,122,000 | $-1,192,090,000 |
| Preferred Securities Outside Stock Equity | $15,507,000 | $18,718,000 | $23,060,000 | $0 |
| Other | ||||
| Ordinary Shares Number | $1,328,600,000 | $1,175,459,000 | $1,068,400,000 | $948,400,000 |
| Share Issued | $1,328,600,000 | $1,175,459,000 | $1,068,400,000 | $948,400,000 |
| Tangible Book Value | $-96,405,000 | $-67,691,000 | $-130,021,000 | $-125,909,000 |
| Invested Capital | $-31,811,000 | $-24,981,000 | $-106,574,000 | $-91,596,000 |
| Working Capital | $-64,212,000 | $-41,079,000 | $-116,580,000 | $-116,479,000 |
| Capital Lease Obligations | $4,764,000 | $4,768,000 | $4,724,000 | $5,543,000 |
| Total Capitalization | $-66,191,000 | $-45,461,000 | $-122,112,000 | $-98,835,000 |
| Additional Paid In Capital | $1,344,720,000 | $1,291,316,000 | $1,164,885,000 | $1,066,873,000 |
| Capital Stock | $1,328,000 | $1,175,000 | $1,068,000 | $948,000 |
| Common Stock | $1,328,000 | $1,175,000 | $1,068,000 | $948,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $4,438,000 | $4,454,000 | $4,370,000 | $5,226,000 |
| Current Capital Lease Obligation | $326,000 | $314,000 | $354,000 | $317,000 |
| Current Accrued Expenses | $2,760,000 | - | - | - |
| Goodwill | $626,000 | $626,000 | $626,000 | $626,000 |
| Net PPE | $20,383,000 | $21,461,000 | $19,635,000 | $19,916,000 |
| Accumulated Depreciation | $-5,553,000 | $-3,856,000 | $-2,272,000 | $-1,084,000 |
| Gross PPE | $25,936,000 | $25,317,000 | $21,907,000 | $21,000,000 |
| Leases | $17,973,000 | $17,785,000 | $13,070,000 | $13,910,000 |
| Other Properties | $4,187,000 | $4,183,000 | $4,189,000 | $4,889,000 |
| Machinery Furniture Equipment | $3,691,000 | $3,263,000 | $2,538,000 | $2,109,000 |
| Land And Improvements | $85,000 | $86,000 | $82,000 | $92,000 |
| Properties | $0 | $0 | $0 | $0 |
| Treasury Shares Number | - | $0 | - | - |
| Construction In Progress | - | $0 | $2,028,000 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-58,031,000 | $-57,074,000 | $-55,677,000 | $-44,314,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-57,017,000 | $-53,637,000 | $-52,775,000 | $-38,299,000 |
| Cash Flow From Continuing Operating Activities | $-57,017,000 | $-53,637,000 | $-52,775,000 | $-38,299,000 |
| Operating Gains Losses | $15,178,000 | $2,045,000 | $28,512,000 | $-239,182,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,014,000 | $-3,437,000 | $-2,902,000 | $-6,015,000 |
| Investing Cash Flow | $-1,014,000 | $-3,437,000 | $-2,902,000 | $-6,015,000 |
| Cash Flow From Continuing Investing Activities | $-1,014,000 | $-3,437,000 | $-2,902,000 | $-6,015,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $22,418,000 | $13,330,000 | $28,134,000 | $4,070,000 |
| Financing Cash Flow | $56,785,000 | $52,758,000 | $41,968,000 | $48,132,000 |
| Cash Flow From Continuing Financing Activities | $56,785,000 | $52,758,000 | $41,968,000 | $48,132,000 |
| Net Other Financing Charges | $250,000 | $4,757,000 | $2,566,000 | $250,000 |
| Net Preferred Stock Issuance | $8,201,000 | $13,330,000 | $18,669,000 | $0 |
| Preferred Stock Issuance | $8,201,000 | $13,330,000 | $18,669,000 | $0 |
| Net Common Stock Issuance | $14,217,000 | $0 | $9,465,000 | $4,070,000 |
| Common Stock Issuance | $14,217,000 | $0 | $9,465,000 | $4,070,000 |
| Other | ||||
| Repayment Of Debt | $-1,433,000 | $-385,000 | $-5,489,000 | $-5,828,000 |
| Issuance Of Debt | $34,015,000 | $33,339,000 | $5,600,000 | $29,665,000 |
| Interest Paid Supplemental Data | $130,000 | $55,000 | $912,000 | $1,730,000 |
| End Cash Position | $2,175,000 | $2,126,000 | $6,965,000 | $15,169,000 |
| Beginning Cash Position | $2,126,000 | $6,965,000 | $15,169,000 | $9,983,000 |
| Effect Of Exchange Rate Changes | $1,295,000 | $-523,000 | $5,505,000 | $1,368,000 |
| Changes In Cash | $-1,246,000 | $-4,316,000 | $-13,709,000 | $3,818,000 |
| Proceeds From Stock Option Exercised | $1,535,000 | $1,717,000 | $11,157,000 | $19,975,000 |
| Net Issuance Payments Of Debt | $32,582,000 | $32,954,000 | $111,000 | $23,837,000 |
| Net Long Term Debt Issuance | $32,582,000 | $32,954,000 | $111,000 | $23,837,000 |
| Long Term Debt Payments | $-1,433,000 | $-385,000 | $-5,489,000 | $-5,828,000 |
| Long Term Debt Issuance | $34,015,000 | $33,339,000 | $5,600,000 | $29,665,000 |
| Net PPE Purchase And Sale | $-1,014,000 | $-3,437,000 | $-2,902,000 | $-6,015,000 |
| Purchase Of PPE | $-1,014,000 | $-3,437,000 | $-2,902,000 | $-6,015,000 |
| Change In Working Capital | $10,003,000 | $-3,695,000 | $7,209,000 | $2,725,000 |
| Change In Other Current Liabilities | $64,000 | $242,000 | $135,000 | $26,000 |
| Change In Other Current Assets | $-7,000 | $-12,000 | $625,000 | $-179,000 |
| Change In Payables And Accrued Expense | $9,845,000 | $-4,426,000 | $6,846,000 | $-597,000 |
| Change In Payable | $9,845,000 | $-4,426,000 | $6,846,000 | $-597,000 |
| Change In Account Payable | $9,845,000 | $-4,426,000 | $6,846,000 | $-597,000 |
| Change In Prepaid Assets | $101,000 | $501,000 | $-397,000 | $3,475,000 |
| Other Non Cash Items | $3,795,000 | $2,450,000 | $2,738,000 | $2,948,000 |
| Stock Based Compensation | $3,456,000 | $4,408,000 | $12,298,000 | $15,498,000 |
| Unrealized Gain Loss On Investment Securities | $-7,715,000 | $2,021,000 | $0 | $0 |
| Depreciation Amortization Depletion | $2,044,000 | $1,733,000 | $1,500,000 | $586,000 |
| Depreciation And Amortization | $2,044,000 | $1,733,000 | $1,500,000 | $586,000 |
| Depreciation | $2,044,000 | $1,733,000 | $1,500,000 | $586,000 |
| Gain Loss On Investment Securities | $785,000 | $-3,358,000 | $25,821,000 | $-239,347,000 |
| Net Income From Continuing Operations | $-83,778,000 | $-62,599,000 | $-105,032,000 | $179,126,000 |
| Net Business Purchase And Sale | - | - | $0 | $0 |
| Purchase Of Business | - | - | $0 | $0 |
| Net Short Term Debt Issuance | - | - | - | $0 |
| Short Term Debt Payments | - | - | - | $0 |
| Short Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-02-02